Remove 2017 Remove Pharmaceutical manufacturing Remove Prescription Remove Safety
article thumbnail

Everything You Need to Know About Market Access in China

PM360

Despite the disruptive impact of the COVID-19 pandemic, steady growth has been evident in China’s pharmaceutical market and research environment. From 2017 to 2022, the Chinese market witnessed a growth rate of 5.3%, compared to the average market growth of 6.6% in the top five European Union markets and 7.1% in the U.S.

Marketing 105